<DOC>
	<DOCNO>NCT01693003</DOCNO>
	<brief_summary>Exercise intolerance major complain patient chronic obstructive pulmonary disease ( COPD ) . Dynamic hyperinflation recognize important limiting factor responsible appearance intolerable dyspnea exercise . Regular treatment long-acting bronchodilator promotes sustain reduction hyperinflation consequent symptom relief increase patient 's ability overcome physical demand daily life . Tiotropium bromide ( TIO ) new generation , long-acting anticholinergic bronchodilator significantly improve lung function , reduce symptom improves exercise tolerance patient advance COPD . Indacaterol new ultra-long duration ( &gt; 24 h ) β2-agonist , promotes sustain dilation bronchus once-daily administration . Compared tiotropium , indacaterol provide evidence effective tiotropium bronchodilation , well clinical outcome dyspnea state health . However , comparative effect indacaterol versus tiotropium regard outcomes tolerance , dyspnea dynamic lung hyperinflation exercise scarce . We hypothesize indacaterol TIO different term exercise tolerance determinant ( dynamic hyperinflation dyspnea ) .</brief_summary>
	<brief_title>Indacaterol Versus Tiotropium Dynamic Hyperinflation COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Men woman ( neither pregnant nurse woman ) ≥40 year age , history smoking ( &gt; 20 years/pack ) COPD diagnosis accord GOLD criterion . Postbronchodilator FEV1 &gt; 50 % &lt; 80 % , FEV1/FVC ≤70 % predict value . Hospital admission due COPD exacerbation lung infection 6 week prior screen , diagnosis current previous bronchial asthma , history allergic rhinitis atopic disease , peripheral eosinophilia &gt; 400/mm3 . Inability discontinue usual bronchodilator therapy prior initial screening test , need continuous oxygen therapy , arterial oxygen saturation &lt; 85 % rest , history adverse reaction sympathomimetic amine use inhaled medication . Anemia , hypo hyperthyroidism , hyperadrenergic condition , uncontrolled insulindependent diabetes mellitus , malignancy , disease condition limit exercise capacity COPD . History drug alcohol abuse , poor adherence drug treatment , treatment investigational drug month screen . Patients ventricular arrhythmia . Patients &lt; 80 % oxyhemoglobin saturation exercise test</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>COPD</keyword>
</DOC>